Status: Completed

Server time: 29.03.2024 15:11

Tender card #RVO/792/2019
LIEKY pre potreby Fakultnej nemocnice s poliklinikou F. D. Roosevelta Banská Bystrica č. 792/2019 v rozsahu IMMUNOPREPARÁTA – Antineoplastické a imunomodulačné činidlá; CYTOSTATIKÁ – Antineoplastické činidlá

Information

ID of tender
4316
Name of content of tender
LIEKY pre potreby Fakultnej nemocnice s poliklinikou F. D. Roosevelta Banská Bystrica č. 792/2019 v rozsahu IMMUNOPREPARÁTA – Antineoplastické a imunomodulačné činidlá; CYTOSTATIKÁ – Antineoplastické činidlá
Tender ref. no.
RVO/792/2019
Public tender journal ref. no.
Vestník č. 144/2019, 18205-MST, z 19.07.2019
EU journal ref. no.
2019/S 137-336827
Type of tender
Nadlimitná zákazka
Type of public tender
Verejná súťaž podľa § 66 (7)
Type of procurement
Goods
Estimated value
5 972 371,9400 EUR
Main CPV
33600000-6 - Pharmaceutical products
Further CPV
33652000-5 - Antineoplastic and immunomodulating agents
33652100-6 - Antineoplastic agents
Tender split into parts
Yes
Centralised tender
No
NUTS
SK - Slovenská republika
Brief description of tender or procurement

Predmetom zákazky je dodávka „LIEKOV pre potreby Fakultnej nemocnice s poliklinikou F. D. Roosevelta Banská Bystrica č. 792/2019 v rozsahu IMMUNOPREPARÁTA – Antineoplastické a imunomodulačné činidlá; CYTOSTATIKÁ – Antineoplastické činidlá“ verejným obstarávateľom požadovanej špecifikácie, vrátane dodania na miesto určenia.

3.1. Predmet zákazky je rozdelený na častí. Uchádzačovi sa umožňuje predložiť ponuku na celý predmet zákazky - na všetkých 48 častí, alebo len na jednu časť predmetu zákazky alebo na viacero častí predmetu zákazky, špecifikovaných v bode „ B – Opis predmetu zákazky „ týchto súťažných podkladov.

For evaluation the price is determined

including VAT

Schedule

Lehota na predkladanie ponúk
26.08.2019 10:00:00
Planned opening of bids
26.08.2019 14:00:00

Public Promoter

Subject's name
Fakultná nemocnica s poliklinikou F.D. Roosevelta Banská Bystrica
Address
Nám. L.Svobodu 1
Banská Bystrica
975 17, Slovak republic
Process supervisor
Zlatica Šeďová
zsedova@nspbb.sk
+421 484413240

Documents

Časť č. 1. Immunoglobulinum humanum

Status
Completed
Predicted value not including VAT
257 871,3600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 2. Albuminum humanum

Status
Completed
Predicted value not including VAT
320 502,3600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 3. Albuminum humanum

Status
Completed
Predicted value not including VAT
51 034,2000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 4. Mofetilis mycophenolas tbl flm alebo tbl ent alebo cps dur 500mg

Status
Completed
Predicted value not including VAT
5 575,6800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 5. Filgrastimum sol ijf alebo sol irs 0,5ml/48MU

Status
Completed
Predicted value not including VAT
15 582,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 6. Filgrastimum sol ijf 0,8ml/48MIU

Status
Completed
Predicted value not including VAT
5 319,2400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 7. Ciclosporinum

Status
Completed
Predicted value not including VAT
3 062,1000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 8. Rituximabum

Status
Completed
Predicted value not including VAT
29 115,8400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 9. Infliximabum plc ifc 100mg/10ml

Status
Completed
Predicted value not including VAT
327 668,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 10. Králičí imunoglobulín proti ľudským tymocytom plv ifo 25mg/ 5 ml

Status
Completed
Predicted value not including VAT
296 144,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

časť č. 11. Belimumab

Status
Completed
Predicted value not including VAT
157 740,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 12. Takrolimu

Status
Completed
Predicted value not including VAT
41 174,4000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 13. Acidum mycofenolicum

Status
Completed
Predicted value not including VAT
9 410,6000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 14. Immunoglobulinum humanum Anti-D Rh sol inj 1 250 IU/ 2ml alebo 1 500 IU/ 2ml

Status
Completed
Predicted value not including VAT
10 437,9000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 15. Immunoglobulinum humanum normale

Status
Completed
Predicted value not including VAT
8 392,4200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 16. Abatacept plc ifc 250mg

Status
Completed
Predicted value not including VAT
122 080,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 17. Basiliximab plv iio 20 mg

Status
Completed
Predicted value not including VAT
173 600,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 18. Rekombinantný interferón beta-1b plv iol 1,2ml /300 ug

Status
Completed
Predicted value not including VAT
34 498,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 19. Anatoxinum tetanicum purificatum sus inj 0,5ml/40 IU

Status
Completed
Predicted value not including VAT
613,8000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 20. Plerixaforum sol inj 1,2ml/24mg

Status
Completed
Predicted value not including VAT
25 800,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

ČaSť č. 21. Ekulizumabum con inf 30ml/300mg

Status
Completed
Predicted value not including VAT
626 666,0400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 22. Peginterferó beta-1a sol inj 0,5ml/125ug pero

Status
Completed
Predicted value not including VAT
60 650,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 23. Natalizumabum con inf 15ml/300mg

Status
Completed
Predicted value not including VAT
80 343,1200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 24. Vedolizumabum plc ifc 300mg

Status
Completed
Predicted value not including VAT
339 616,4000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 25. Alemtuzumabum con inf 1,2ml/12mg

Status
Completed
Predicted value not including VAT
227 568,3200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 26. Ustekinumabum

Status
Completed
Predicted value not including VAT
130 750,0400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 27. Proteinum plasmatis humani sol inf 200ml/ 9 - 14g

Status
Completed
Predicted value not including VAT
1 661,5200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 28. Lyofilizovaný dialyzát leukocytov plv iol 4ml/ 200 miliónov leukocytov

Status
Completed
Predicted value not including VAT
12 018,0800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 29. Mycophenolatum mofetilum plc ifc 500mg

Status
Completed
Predicted value not including VAT
249,2000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 30. Bacillus Calmette-Guérin baktérie plv suf

Status
Completed
Predicted value not including VAT
27 841,6600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 31. Azatioprínum tbl flm 50mg

Status
Completed
Predicted value not including VAT
291,9800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 32. Sirolimus tbl obd 1mg

Status
Completed
Predicted value not including VAT
1 887,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 33.Azoximeri bromidum lyo ijo 6mg

Status
Completed
Predicted value not including VAT
638,3200 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť č. 34. Okrelizumabum con inf 10ml/300mg

Status
Completed
Predicted value not including VAT
145 658,5600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652000-5 - Antineoplastic and immunomodulating agents
Outcome of tender
Framework Agreement

Časť. 35. Cetuximabum sol inf 20ml/100mg

Status
Completed
Predicted value not including VAT
445 176,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 36. Panitumumabum

Status
Completed
Predicted value not including VAT
3 485,4600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 37. Dabrafenibum cps dur 75mg

Status
Completed
Predicted value not including VAT
49 059,4000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 38. Pemrolizumabum con inf 4ml/100mg

Status
Completed
Predicted value not including VAT
1 579 446,0800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 39. Krizotinib

Status
Completed
Predicted value not including VAT
58 218,6000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 40. Osimertinib tbl flm 80mg

Status
Completed
Predicted value not including VAT
9 067,9000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 41. Trifluridín

Status
Completed
Predicted value not including VAT
158 616,4000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 42. Cytarabinum

Status
Completed
Predicted value not including VAT
15 251,3600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 43. Oxaliplatina

Status
Completed
Predicted value not including VAT
23 104,0000 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 44. Paklitaxel

Status
Completed
Predicted value not including VAT
27 822,6800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č.45. Ramucirumabum con inf 10 ml/100 mg

Status
Completed
Predicted value not including VAT
23 660,2800 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 46. Vinorelbinum con inf 50 mg/5ml

Status
Completed
Predicted value not including VAT
14 565,6600 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 47. Vinorelbinum con inf 50 mg/5ml v SPC registrovaná indikácia karcinóm prsníka a karcinóm prostaty

Status
Completed
Predicted value not including VAT
6 024,5400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement

Časť č. 48. Trastuzumabum plc ifc 150 mg

Status
Completed
Predicted value not including VAT
7 411,4400 EUR
Criterion for evaluation of bid
Lowest price
Electronic auction
Yes
Main CPV
33652100-6 - Antineoplastic agents
Outcome of tender
Framework Agreement